Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 20:04:18 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

Alzinova - Positive topline results

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Alzinova - Positive topline results

2023-12-04 08:29:00

Redeye provides a short research update following the positive phase Ib results with lead candidate ALZ-101 published by Alzinova last week. Overall, we are encouraged to learn that the candidate met the primary endpoint of safety and tolerability, while demonstrating a clear immunological response related to treatment. We raise our base case valuation to SEK12 (10) as we see an increased likelihood of approval (LoA) for ALZ-101 following the results.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/